Codexis

CDXS49

Penny Stock

$4.61arrow_drop_up6.35%$0.27

Penny Stock

CDXS49

$4.61

arrow_drop_up6.35%$0.27

Penny Stock

Performance History

Key Stats
Open	$4.37
Prev. Close	$4.33
EPS	-0.88
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$375.15M
PE Ratio	-

	LOW	HIGH
Day Range	4.32	4.69
52 Week Range	1.51	4.91

Ratios







EPS	-0.88

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Codexis (CDXS)

Codexis Inc (CDXS) is a company engaged in the development of biocatalysts for the pharmaceutical and fine chemicals industries. The company's focus is on optimizing protein engineering platforms to enable the discovery and development of novel enzymes for use in various applications. CDXS has a strong track record of collaborating with major pharmaceutical companies and is known for its expertise in protein engineering and biocatalysis.

CDXS has a solid stock price history, with gradual but steady growth over the years. The company's stock price has generally remained stable, with occasional fluctuations in response to industry trends and market conditions. As of the latest available data, CDXS trades at $15.74 per share.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Stephen George Dilly MBBS, Ph.D.
Headquarters: Redwood City
Employees: 248
Exchange: NASDAQ

Keep an eye on Codexis

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Codexis 's (CDXS) price per share?

The current price per share for Codexis (CDXS) is $4.61. The stock has seen a price change of $0.28 recently, indicating a 6.35% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Codexis (CDXS)?

For Codexis (CDXS), the 52-week high is $4.91, which is 6.51% from the current price. The 52-week low is $1.51, the current price is 205.3% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Codexis (CDXS) a growth stock?

Codexis (CDXS) has shown an average price growth of -4.13% over the past three years. It has received a score of 36 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Codexis as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Codexis (CDXS) stock price performance year to date (YTD)?

As of the latest data, Codexis (CDXS) has a year-to-date price change of 47.76%. Over the past month, the stock has experienced a price change of 39.7%. Over the last three months, the change has been 58.97%. Over the past six months, the figure is 32.85%. Looking at a longer horizon, the five-year price change stands at -69.79%.

help

Is Codexis (CDXS) a profitable company?

Codexis (CDXS) has a net income of -$76.24M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 81.74% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -129.02% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $70.14M, although specific revenue growth data is currently not available. The gross profit is $57.33M. Operating income is noted at -$68.07M. Furthermore, the EBITDA is -$45.78M.

help

What is the market capitalization of Codexis (CDXS)?

Codexis (CDXS) has a market capitalization of $375.15M. The average daily trading volume is 4.57, indicating the stock's liquidity and investor engagement.